Robert Carey Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Robert Carey.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Robert Carey. Robert Carey is Director in SANGAMO BIOSCIENCES INC ($SGMO) and Director in ARGOS THERAPEUTICS INC ($ARGS) and EVP & Chief Business Officer in Horizon Pharma plc ($HZNP) and EVP, Chief Business Officer in Horizon Pharma plc ($HZNP) and Director in AIT Therapeutics, Inc. ($AITB).
Latest Insider Trading Transactions of Robert Carey
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARGS, AITB, HZNP, SGMO
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 08 2021 | AITB | Beyond Air, Inc. | Carey Robert | Director | Option Exercise | A | 5.45 | 25,000 | 136,250 | 25,000 | |
| Mar 05 2021 | AITB | Beyond Air, Inc. | Carey Robert | Director | Buy | P | 5.70 | 17,000 | 96,900 | 131,418 | 114.4 K to 131.4 K (+14.86 %) |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Carey Robert | Director | Option Exercise | A | 11.19 | 16,400 | 183,516 | 16,400 | |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Carey Robert | Director | Grant | A | 0.00 | 8,200 | 0 | 23,200 | 15 K to 23.2 K (+54.67 %) |
| Aug 26 2020 | AITB | Beyond Air, Inc. | Carey Robert | Director | Buy | P | 5.70 | 10,000 | 57,000 | 99,418 | 89.4 K to 99.4 K (+11.18 %) |
| Aug 18 2020 | AITB | Beyond Air, Inc. | Carey Robert | Director | Buy | P | 5.65 | 50,000 | 282,500 | 89,418 | 39.4 K to 89.4 K (+126.85 %) |
| Aug 18 2020 | AITB | Beyond Air, Inc. | Carey Robert | Director | Buy | P | 5.50 | 10,000 | 55,000 | 39,418 | 29.4 K to 39.4 K (+33.99 %) |
| Aug 17 2020 | AITB | Beyond Air, Inc. | Carey Robert | Director | Buy | P | 5.30 | 5,000 | 26,500 | 29,418 | 24.4 K to 29.4 K (+20.48 %) |
| Aug 17 2020 | AITB | Beyond Air, Inc. | Carey Robert | Director | Buy | P | 5.45 | 5,000 | 27,250 | 24,418 | 19.4 K to 24.4 K (+25.75 %) |
| May 20 2020 | SGMO | SANGAMO THERAPEUTI ... | Carey Robert | Director | Option Exercise | A | 10.46 | 15,000 | 156,900 | 15,000 | |
| May 20 2020 | SGMO | SANGAMO THERAPEUTI ... | Carey Robert | Director | Grant | A | 0.00 | 2,500 | 0 | 7,500 | 5 K to 7.5 K (+50.00 %) |
| Nov 22 2019 | AITB | Beyond Air, Inc. | Carey Robert | Director | Buy | P | 5.15 | 19,418 | 100,003 | 19,418 | 0 to 19.4 K |
| Jun 12 2019 | SGMO | SANGAMO THERAPEUTI ... | Carey Robert | Director | Option Exercise | A | 9.38 | 15,000 | 140,700 | 15,000 | |
| Jun 12 2019 | SGMO | SANGAMO THERAPEUTI ... | Carey Robert | Director | Grant | A | 0.00 | 2,500 | 0 | 5,000 | 2.5 K to 5 K (+100.00 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Option Exercise | M | 0.00 | 31,000 | 0 | 0 | |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Option Exercise | M | 0.00 | 31,000 | 0 | 0 | |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Payment of Exercise | F | 26.84 | 13,733 | 368,594 | 17,267 | 31 K to 17.3 K (-44.30 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Payment of Exercise | F | 26.84 | 13,733 | 368,594 | 17,267 | 31 K to 17.3 K (-44.30 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Buy | M | 0.00 | 31,000 | 0 | 31,000 | 0 to 31 K |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Buy | M | 0.00 | 31,000 | 0 | 31,000 | 0 to 31 K |
| Feb 22 2019 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Payment of Exercise | F | 21.54 | 32,064 | 690,659 | 40,311 | 72.4 K to 40.3 K (-44.30 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Grant | A | 0.00 | 72,375 | 0 | 72,375 | 0 to 72.4 K |
| Feb 22 2019 | AITB | AIT Therapeutics, ... | Carey Robert | Director | Option Exercise | A | 4.95 | 25,000 | 123,750 | 25,000 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Option Exercise | M | 0.00 | 65,695 | 0 | 131,392 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Option Exercise | M | 0.00 | 65,695 | 0 | 131,392 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Option Exercise | A | 0.00 | 53,948 | 0 | 53,948 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Option Exercise | A | 0.00 | 53,948 | 0 | 53,948 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Payment of Exercise | F | 20.39 | 29,419 | 599,853 | 36,276 | 65.7 K to 36.3 K (-44.78 %) |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Payment of Exercise | F | 20.39 | 29,419 | 599,853 | 36,276 | 65.7 K to 36.3 K (-44.78 %) |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Buy | M | 0.00 | 65,695 | 0 | 65,695 | 0 to 65.7 K |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Buy | M | 0.00 | 65,695 | 0 | 65,695 | 0 to 65.7 K |
| Jun 12 2018 | SGMO | SANGAMO THERAPEUTI ... | Carey Robert | Director | Option Exercise | A | 15.65 | 15,000 | 234,750 | 15,000 | |
| Jun 12 2018 | SGMO | SANGAMO THERAPEUTI ... | Carey Robert | Director | Grant | A | 0.00 | 2,500 | 0 | 2,500 | 0 to 2.5 K |
| May 07 2018 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Option Exercise | A | 0.00 | 197,087 | 0 | 197,087 | |
| May 07 2018 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Option Exercise | A | 0.00 | 197,087 | 0 | 197,087 | |
| Mar 27 2018 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Option Exercise | M | 0.00 | 31,000 | 0 | 31,000 | |
| Mar 27 2018 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Payment of Exercise | F | 13.86 | 9,083 | 125,890 | 39,106 | 48.2 K to 39.1 K (-18.85 %) |
| Mar 27 2018 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Buy | M | 0.00 | 31,000 | 0 | 48,189 | 17.2 K to 48.2 K (+180.35 %) |
| Mar 07 2018 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Option Exercise | M | 0.00 | 31,025 | 0 | 0 | |
| Mar 07 2018 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Payment of Exercise | F | 15.83 | 13,836 | 219,024 | 17,189 | 31 K to 17.2 K (-44.60 %) |
| Mar 07 2018 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Buy | M | 0.00 | 31,025 | 0 | 31,025 | 0 to 31 K |
| Jun 07 2017 | SGMO | SANGAMO THERAPEUTI ... | Carey Robert | Director | Option Exercise | A | 7.20 | 10,000 | 72,000 | 10,000 | |
| Mar 24 2017 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Option Exercise | M | 0.00 | 31,000 | 0 | 62,000 | |
| Mar 24 2017 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Payment of Exercise | F | 14.56 | 14,167 | 206,272 | 34,190 | 48.4 K to 34.2 K (-29.30 %) |
| Mar 24 2017 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Buy | M | 0.00 | 31,000 | 0 | 48,357 | 17.4 K to 48.4 K (+178.60 %) |
| Mar 07 2017 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Option Exercise | M | 0.00 | 31,025 | 0 | 31,025 | |
| Mar 07 2017 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Payment of Exercise | F | 16.11 | 14,268 | 229,857 | 17,357 | 31.6 K to 17.4 K (-45.12 %) |
| Mar 07 2017 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Buy | M | 0.00 | 31,025 | 0 | 31,625 | 600 to 31.6 K (+5,170.83 %) |
| Mar 02 2017 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Option Exercise | X | 4.31 | 6,913 | 29,781 | 0 | |
| Mar 02 2017 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Sell | S | 16.00 | 30,000 | 480,000 | 95,408 | 125.4 K to 95.4 K (-23.92 %) |
| Mar 02 2017 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Sell | S | 16.48 | 1,808 | 29,796 | 125,408 | 127.2 K to 125.4 K (-1.42 %) |
| Mar 02 2017 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Buy | X | 4.31 | 6,913 | 29,781 | 127,216 | 120.3 K to 127.2 K (+5.75 %) |
| Jan 20 2017 | ARGS | ARGOS THERAPEUTICS ... | Carey Robert | Director | Option Exercise | A | 4.85 | 9,500 | 46,075 | 9,500 | |
| Jan 04 2017 | ARGS | ARGOS THERAPEUTICS ... | Carey Robert | Director | Grant | A | 0.00 | 2,351 | 0 | 8,206 | 5.9 K to 8.2 K (+40.15 %) |
| Oct 03 2016 | ARGS | ARGOS THERAPEUTICS ... | Carey Robert | Director | Grant | A | 0.00 | 2,263 | 0 | 5,855 | 3.6 K to 5.9 K (+63.00 %) |
| Jul 05 2016 | ARGS | ARGOS THERAPEUTICS ... | Carey Robert | Director | Grant | A | 0.00 | 1,835 | 0 | 3,592 | 1.8 K to 3.6 K (+104.44 %) |
| Jun 15 2016 | SGMO | SANGAMO BIOSCIENCE ... | Carey Robert | Director | Option Exercise | A | 5.99 | 30,000 | 179,700 | 30,000 | |
| Jun 14 2016 | ARGS | ARGOS THERAPEUTICS ... | Carey Robert | Director | Option Exercise | A | 7.41 | 5,500 | 40,755 | 5,500 | |
| Apr 04 2016 | ARGS | ARGOS THERAPEUTICS ... | Carey Robert | Director | Grant | A | 0.00 | 1,757 | 0 | 1,757 | 0 to 1.8 K |
| Mar 24 2016 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Option Exercise | M | 0.00 | 31,000 | 0 | 93,000 | |
| Mar 24 2016 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Payment of Exercise | F | 16.32 | 14,167 | 231,205 | 38,242 | 52.4 K to 38.2 K (-27.03 %) |
| Mar 24 2016 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Buy | M | 0.00 | 31,000 | 0 | 52,409 | 21.4 K to 52.4 K (+144.80 %) |
| Mar 07 2016 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Option Exercise | M | 0.00 | 31,025 | 0 | 62,050 | |
| Mar 07 2016 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Payment of Exercise | F | 16.78 | 9,616 | 161,356 | 21,409 | 31 K to 21.4 K (-30.99 %) |
| Mar 07 2016 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Buy | M | 0.00 | 31,025 | 0 | 31,025 | 0 to 31 K |
| Mar 07 2016 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Gift | G | 0.00 | 24,406 | 0 | 82,061 | 57.7 K to 82.1 K (+42.33 %) |
| Mar 07 2016 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Gift | G | 0.00 | 24,406 | 0 | 0 | 24.4 K to 0 (-100.00 %) |
| May 08 2015 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Option Exercise | A | 0.00 | 699,000 | 0 | 699,000 | |
| Mar 25 2015 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Option Exercise | A | 0.00 | 233,000 | 0 | 233,000 | |
| Mar 25 2015 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Option Exercise | A | 0.00 | 124,000 | 0 | 124,000 | |
| Mar 25 2015 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Option Exercise | A | 22.14 | 276,000 | 6,110,640 | 276,000 | |
| Mar 09 2015 | HZNP | Horizon Pharma plc | Carey Robert | EVP & Chief Busines ... | Option Exercise | M | 0.00 | 31,025 | 0 | 93,075 | |
| Mar 09 2015 | HZNP | Horizon Pharma plc | Carey Robert | EVP & Chief Busines ... | Payment of Exercise | F | 20.84 | 9,736 | 202,898 | 23,245 | 33 K to 23.2 K (-29.52 %) |
| Mar 09 2015 | HZNP | Horizon Pharma plc | Carey Robert | EVP & Chief Busines ... | Buy | M | 0.00 | 31,025 | 0 | 32,981 | 2 K to 33 K (+1,586.15 %) |
| Mar 07 2014 | HZNP | Horizon Pharma plc | Carey Robert | EVP & Chief Busines ... | Option Exercise | A | 0.00 | 124,100 | 0 | 124,100 | |
| Mar 07 2014 | HZNP | Horizon Pharma plc | Carey Robert | EVP & Chief Busines ... | Option Exercise | A | 13.34 | 100,000 | 1,334,000 | 100,000 | |
| Mar 07 2014 | HZNP | Horizon Pharma plc | Carey Robert | EVP & Chief Busines ... | Option Exercise | A | 13.34 | 140,000 | 1,867,600 | 140,000 |
Page: 1